Detected NRAS mutations occurred exclusively at the known hotspot residues p.G12, p.G13, and p.Q61 representing gain of function mutations in various cancer entities including multiple myeloma (MM)25–27. The gene discussed is NRAS; the disease is AL amyloidosis.